A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer

Clinical trial NCT01304784 · COMPLETED

Trial details

NCT number: NCT01304784
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER-2 Gene Amplification

Start date: 2011-01-01
Primary completion: 2014-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.